Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsA groundbreaking study reveals that combining ixekizumab and tirzepatide significantly improves outcomes for adults with psoriatic arthritis and obesity.
Coya Therapeutics reveals promising results for COYA 302, a potential treatment for frontotemporal dementia, showing cognitive stability and Treg enhancement.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on the International Stroke Conference (ISC)!
Here's some of what is coming soon to NeurologyLive® this week.
FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy
1.
High levels of traumatic stress found in caregivers of adult cancer patients
2.
Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC
3.
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer
4.
Losing a reward can affect your motivation and performance.
5.
Study: Rapamycin slows the progression of cancer by reducing aging and concentrating on precancerous cells.
1.
Everything You Need to Know About CA 19-9 and Cancer Diagnosis
2.
Optimizing Oncology Practice Revenue: Billing Software, Payer Trends, and Financial Navigation Tools
3.
Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC
4.
Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management
5.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XII
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation